There’s no ‘best’ vaccine, expert says as Canada OKs AstraZeneca shots Twinkle Ghosh © University of Oxford/John Cairns via AP, File In this undated file photo issued by the University of Oxford on Monday, Nov. 23, 2020, a researcher in a laboratory at the Jenner Institute in Oxford, England, works on the coronavirus vaccine developed by AstraZeneca and Oxford University.
Vaccines from Moderna, Pfizer-BioNTech and AstraZeneca-Oxford have now been approved in Canada. While Canadians may not get a choice about which COVID-19 vaccine to take, all three offer protection against severe illness, according to experts.
“All of these vaccines are good,” Dr. Bradly Wouters, executive vice-president of science and research at the University Health Network told Global News Friday.
Stocks Extend Rally On Virus, Stimulus Optimism
ibtimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ibtimes.com Daily Mail and Mail on Sunday newspapers.
Many Stocks Boosted By Stimulus, Virus Optimism
ibtimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ibtimes.com Daily Mail and Mail on Sunday newspapers.
Stocks Struggle As Oil Gushes
ibtimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ibtimes.com Daily Mail and Mail on Sunday newspapers.
ksuadminFebruary 3, 2021 31
The number of global vaccinations against Covid-19 has exceeded the total number of confirmed cases, a remarkable moment that highlights the progress being made to contain the pandemic, despite growing concern over the threat of new variants.
According to the Financial Times vaccine tracker, the number of doses administered approached 104 million on Wednesday (3), while the number of confirmed cases was just over 103 million.
Vaccination rates are accelerating rapidly, but the increase in Covid-19 cases is slowing, due to measures other than vaccines, as they have not yet affected transmission in most places.
Data is incomplete due to the fragmented nature of the reports – and the actual number of infections is likely to be several times greater than that verified by diagnostic tests.